Found: 3
Select item for more details and to access through your institution.
Tislelizumab Combined with Carboplatin-Paclitaxel for Treatment of Metastatic or Recurrent Endometrial Cancer: a Retrospective Clinical Study.
- Published in:
- Clinical Laboratory, 2022, v. 68, n. 11, p. 2248, doi. 10.7754/Clin.Lab.2022.211221
- By:
- Publication type:
- Article
Suppression of SIK1 by miR-141 in human ovarian cancer cell lines and tissues.
- Published in:
- International Journal of Molecular Medicine, 2016, v. 37, n. 6, p. 1601, doi. 10.3892/ijmm.2016.2553
- By:
- Publication type:
- Article
TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro.
- Published in:
- Oncology Letters, 2014, v. 7, n. 3, p. 871, doi. 10.3892/ol.2013.1759
- By:
- Publication type:
- Article